obesity drug news today glp-1 october 27 2025 2024 was a record year for trials and is already poised to take over Study identifies benefits, risks linked

The pills safety and tolerability was similar to the injectable version of Wegovy, Novo Nordisk said

HRAs are funded entirely by your employer and governed by an employer-written plan document that can exclude weight-loss medications, require prior approval, or demand a Letter of Medical Necessity (LMN) before reimbursement

As neurological and medical complications after stroke are not properly predicted, prevented, or dealt with, they are considered to constitute the main cause of the high morbidity and mortality associated with strokes (78)

Cost: Zepbound costs $1059.87 per month without insurance

The FDA advisory on GLP-1s specifically mentions medullary thyroid cancer

In rare, carefully controlled situations when a patient is facing otherwise life-threatening inflammatory disease the clinician and patient may decide the risk is worth it